Cadila Healthcare gets USFDA final approval for Mesalamine tablets

-
Cadila Healthcare on Wednesday announced that USFDA has given final approval to market Mesalamine Delayed-Released tablets USP, 1.2g in the US market. Zydus Cadila was the first to file an ANDA for a generic version of Lialda (mesalamine).

Lialda is used for the treatment of mild to moderate ulcerative colitis. Ulcerative colitis is a chronic inflammatory bowel disease that affects approximately 700,000 people in the United States. The generic version of Lialda (mesalamine) will be produced at Moraiya Plant located at Ahmedabad. The estimated brand sale for Mesalamine Delayed-Release tablets USP, 1.2g is USD 1.145 billion as per IMS MAT April 2017.

The group now has more than 115 approvals and has so far filler over 300 ANDAs since the commencement of the filling process in FY 2003-2004.

Stock view :-

Cadila Healthcare Ltd is currently trading at Rs 533.5, up by Rs 43.1 or 8.79% from its previous closing of Rs 490.4 on the BSE.

The scrip opened at Rs 493 and has touched a high and low of Rs 539.4 and Rs 491.05 respectively. So far 5606804(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 50204.34 crore.

The BSE group 'A' stock of face value Rs 1 has touched a 52 week high of Rs 510 on 06-Jun-2017 and a 52 week low of Rs 305.05 on 24-Jun-2016. Last one week high and low of the scrip stood at Rs 510 and Rs 461.3 respectively.

The promoters holding in the company stood at 74.79 % while Institutions and Non-Institutions held 17.14 % and 8.07 % respectively.
The stock is currently trading above its 50 DMA.

Cadila Healthcare Ltd :-
BSE 533.50 43.10 (8.79%)
NSE 533.55 44.05 (9%)


Comments

Post a Comment

Popular posts from this blog

Top intraday trading ideas for afternoon trade for Monday 31 December 2018

-
Image
Top intraday trading ideas for afternoon trade for Monday 31 December 2018  NEW DELHI:    Equity benchmarks Sensex and Nifty50 were trading higher on Monday on account of buying in frontline bluechip counters. Markets collated a list of trading ideas from various experts and here's what they had recommended for today's afternoon trade: Manas Jaiswal of manasjaiswal.com Tata Steel is a 'Buy' call with a target price of Rs 540 and a stop loss of Rs 514. Shriram Transport NSE 2.17 % is a 'Buy' call with a target price of Rs 1300 and a stop loss of Rs 1230. NSE LIVE 11:49 | 31-12-2018 Dr. Reddy's Lab is a 'Buy' call with a target price of Rs 2720 and a stop loss of Rs 2630. Kunal Bothra independent market expert Dr. Reddy's Lab is a 'Buy' call with a target price of Rs 2750 and a stop loss of Rs 2600. Chennai Petroleum is a 'Buy' call with a target price of Rs 306 and a stop los...
Read more

WELCOME TO SMART MONEY FINANCIAL SERVICES

-
Image
               WELCOME TO SMART MONEY FS               WE CREATE THE OPPORTUNITY   "Smart Money Financial Service" is an Investment Advisory having a team consists of highly qualified analysts who are skilled and impeccable in their analysis. These analysts, using their experience and the latest software tools, are able to predict the movements in share market on time and with high accuracy. Please click here for Advisory Ranking: As a result, using our tips, our clients gain the most out of the share market. We provide recommendations for Stocks – Cash and F & O trad. 1. VISION GrowthPress focuses on conducting in-depth research on your customers, your competitors, and your search engine landscape. Using this, we create the right SEO strategy that helps. 2. MISSION You achieve your goals. Search engines are constantly evolving to reflect the complex human behavior. Thus, ...
Read more

F&O: Put writing at all immediate strikes shows Nifty may hold up

-
Image
F&O: Put writing at all immediate strikes shows Nifty may hold up  The Nifty50 index opened in the negative but managed to recover sharply from lower levels and headed towards the 10,750 level on Wednesday. It formed a Piercing Line pattern on the daily scale, as it recovered its losses of the last session by more than a half. It has been making lower lows from last four sessions and holds above the 10,750-10,777 zone can negate the same to extend its recent bounce towards 10,850 and then 10,929 levels.  Nifty has reclaimed its 50-day EMA while on the downside it has support at 10,650 and then 10,600 levels.  On the options front, maximum Put OI was at 10,000 followed by 10,500 and 10,700 levels, while maximum Call OI was at 11,000 followed by 10,900 level. Meaningful Put writing was seen at all the immediate strike prices from 10,650 to 10,500 level, which suggests support is intact while Call unwinding was seen at most strike prices till 11,000 level. The...
Read more